Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |